Adenosine Thiamine Triphosphate (AThTP) Inhibits Poly(ADP-Ribose) Polymerase-1 (PARP-1) Activity

  • TANAKA Takao
    Organization of Medical Education, Osaka Medical College
  • YAMAMOTO Daisuke
    Biomedical Computation Center, Osaka Medical College
  • SATO Takaji
    Laboratory of Analytical Chemistry, Osaka University of Pharmaceutical Sciences
  • TANAKA Sunao
    Human Health Sciences, Graduate School of Medicine Kyoto University
  • USUI Kazuya
    Laboratory of Pharmacotherapy, Osaka University of Pharmaceutical Sciences
  • MANABE Miki
    Laboratory of Pharmacotherapy, Osaka University of Pharmaceutical Sciences
  • AOKI Yui
    Laboratory of Analytical Chemistry, Osaka University of Pharmaceutical Sciences
  • IWASHIMA Yasuki
    Laboratory of Analytical Chemistry, Osaka University of Pharmaceutical Sciences
  • SAITO Yoshihiro
    Laboratory of Analytical Chemistry, Osaka University of Pharmaceutical Sciences
  • MINO Yoshiki
    Laboratory of Analytical Chemistry, Osaka University of Pharmaceutical Sciences
  • DEGUCHI Hirofumi
    Organization of Medical Education, Osaka Medical College

この論文をさがす

抄録

Overactivation of poly(ADP-ribose) polymerase-1 (PARP-1) has been demonstrated to result in various stress-related diseases, including diabetes mellitus. Deficiency of cellular nicotinamide adenine dinucleotide (NAD+) content, consumed by PARP-1 to add ADP-ribose moieties onto target proteins, contributes to pathophysiological conditions. Adenosine thiamine triphosphate (AThTP) exists in small amounts in mammals; however, the function(s) of this metabolite remains unresolved. The structure of AThTP resembles NAD+. Recent experimental studies demonstrate beneficial impacts of high-dose thiamine treatment of diabetic complications. These findings have led us to hypothesize that AThTP may modulate the activity of PARP-1. We have chemically synthesized AThTP and evaluated the effect of AThTP on recombinant PARP-1 enzyme activity. AThTP inhibited the PARP-1 activity at 10 μM, and a structural model of the PARP-1-AThTP complex highlighted the AThTP binding site. The results provide new insights into the pharmacological importance of AThTP as an inhibitor of PARP-1.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (41)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ